Standard chemotherapy for disseminated germ-cell tumors includes a combination of cisplatin, vinblastine, and bleomycin, but this regimen produces substantial neuromuscular toxicity. In a randomized clinical trial in 261 men with disseminated germ-cell tumors, we substituted etoposide for the vinblastine in this regimen in half the patients to compare the efficacy and toxicity of the two treatments. Among 244 patients who could be evaluated for a response, 74 percent of those receiving the regimen including vinblastine and 83 percent of those receiving the regimen including etoposide became disease-free with or without subsequent surgery (P not significant). Among the 157 patients with high tumor volume, 61 percent became disease-free on the regimen that included vinblastine, as compared with 77 percent on the regimen that included etoposide (P less than 0.05). Survival among the patients who received etoposide was higher (P = 0.048). The regimens were similar in terms of myelosuppressive effects and pulmonary toxicity. However, the etoposide regimen caused substantially fewer paresthesias (P = 0.02), abdominal cramps (P = 0.0008), and myalgias (P = 0.00002). We conclude that etoposide with cisplatin and bleomycin is superior to vinblastine with cisplatin and bleomycin in the treatment of disseminated germ-cell tumors because of diminished neuromuscular toxicity and, among patients with advanced disease, better efficacy.
This article has been cited by other articles:
Brydoy, M., Oldenburg, J., Klepp, O., Bremnes, R. M., Wist, E. A., Wentzel-Larsen, T., Hauge, E. R., Dahl, O., Fossa, S. D.
(2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. JNCI J Natl Cancer Inst
0: djp413v1-1695
[Abstract][Full Text]
Sato, S., Tanaka, T., Takahashi, A., Sasai, M., Kitamura, H., Masumori, N., Tsukamoto, T.
(2009). Late Recurrence and Second Primary Malignancy among 139 Patients with Germ Cell Tumors: Long-term Outcome of the Disease in a Single-center Experience. Jpn J Clin Oncol
0: hyp142v1-hyp142
[Abstract][Full Text]
White, M. A., DeHaan, A. P., Wilson, J. M., Zakem, M. H., Maatman, T. J.
(2009). Synchronous Advanced Pure Seminoma and Diffuse Large B-Cell Lymphoma: A Case of Multiple Oncologic Dilemmas. JCO
27: e181-e183
[Full Text]
de La Motte Rouge, T., Pautier, P., Duvillard, P., Rey, A., Morice, P., Haie-Meder, C., Kerbrat, P., Culine, S., Troalen, F., Lhomme, C.
(2008). Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol
19: 1435-1441
[Abstract][Full Text]
Marcon, L., Hales, B. F., Robaire, B.
(2008). Reversibility of the Effects of Subchronic Exposure to the Cancer Chemotherapeutics Bleomycin, Etoposide, and Cisplatin on Spermatogenesis, Fertility, and Progeny Outcome in the Male Rat. J Androl
29: 408-417
[Abstract][Full Text]
de Haas, E. C., Zwart, N., Meijer, C., Nuver, J., Boezen, H. M., Suurmeijer, A. J.H., Hoekstra, H. J., van der Steege, G., Sleijfer, D. Th., Gietema, J. A.
(2008). Variation in Bleomycin Hydrolase Gene Is Associated With Reduced Survival After Chemotherapy for Testicular Germ Cell Cancer. JCO
26: 1817-1823
[Abstract][Full Text]
Villano, J. L., Propp, J. M., Porter, K. R., Stewart, A. K., Valyi-Nagy, T., Li, X., Engelhard, H. H., McCarthy, B. J.
(2008). Malignant pineal germ-cell tumors: An analysis of cases from three tumor registries. Neuro Oncol Duke
10: 121-130
[Abstract][Full Text]
Shintaku, I., Satoh, M., Okajima, E., Fujimoto, H., Kamoto, T., Ogawa, O., Kawai, K., Akaza, H., Tsukamoto, T., Naito, S., Miki, T., Arai, Y.
(2008). Survival of Metastatic Germ Cell Cancer Patients Assessed by International Germ Cell Consensus Classification in Japan. Jpn J Clin Oncol
38: 281-287
[Abstract][Full Text]
Feldman, D. R., Bosl, G. J., Sheinfeld, J., Motzer, R. J.
(2008). Medical Treatment of Advanced Testicular Cancer. JAMA
299: 672-684
[Abstract][Full Text]
Culine, S., Kramar, A., Theodore, C., Geoffrois, L., Chevreau, C., Biron, P., Nguyen, B. B., Heron, J.-F., Kerbrat, P., Caty, A., Delva, R., Fargeot, P., Fizazi, K., Bouzy, J., Droz, J.-P.
(2008). Randomized Trial Comparing Bleomycin/Etoposide/Cisplatin With Alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin Regimens of Chemotherapy for Patients With Intermediate- and Poor-Risk Metastatic Nonseminomatous Germ Cell Tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. JCO
26: 421-427
[Abstract][Full Text]
van den Belt-Dusebout, A. W., de Wit, R., Gietema, J. A., Horenblas, S., Louwman, M. W.J., Ribot, J. G., Hoekstra, H. J., Ouwens, G. M., Aleman, B. M.P., van Leeuwen, F. E.
(2007). Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer. JCO
25: 4370-4378
[Abstract][Full Text]
Khan, O., Protheroe, A.
(2007). Testis cancer. Postgrad. Med. J.
83: 624-632
[Abstract][Full Text]
Einhorn, L. H., Williams, S. D., Chamness, A., Brames, M. J., Perkins, S. M., Abonour, R.
(2007). High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors. NEJM
357: 340-348
[Abstract][Full Text]
Gershenson, D. M.
(2007). Management of Ovarian Germ Cell Tumors. JCO
25: 2938-2943
[Abstract][Full Text]
Culine, S, Kerbrat, P, Kramar, A, Theodore, C, Chevreau, C, Geoffrois, L, Bui, N., Peny, J, Caty, A, Delva, R, Biron, P, Fizazi, K, Bouzy, J, Droz, J.
(2007). Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP). Ann Oncol
18: 917-924
[Abstract][Full Text]
Motzer, R. J., Nichols, C. J., Margolin, K. A., Bacik, J., Richardson, P. G., Vogelzang, N. J., Bajorin, D. F., Lara, P. N. Jr, Einhorn, L., Mazumdar, M., Bosl, G. J.
(2007). Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors. JCO
25: 247-256
[Abstract][Full Text]
Sonpavde, G., Hutson, T. E., Roth, B. J.
(2007). Management of Recurrent Testicular Germ Cell Tumors. The Oncologist
12: 51-61
[Abstract][Full Text]
Bajorin, D. F., Motzer, R. J., Bosl, G. J.
(2006). Advances in Urologic Oncology: Results Progress From Successful Interdisciplinary Research. JCO
24: 5479-5481
[Full Text]
Kondagunta, G. V., Motzer, R. J.
(2006). Chemotherapy for Advanced Germ Cell Tumors. JCO
24: 5493-5502
[Abstract][Full Text]
Kawai, K., Hinotsu, S., Oikawa, T., Sekido, N., Hattori, K., Miyanaga, N., Hasegawa, Y., Kojima, H., Shimazui, T., Akaza, H.
(2006). Treatment Outcome of Metastatic Testicular Cancer at a Single Institution in Japan, a Country with Low Incidence of Germ Cell Tumor. Jpn J Clin Oncol
36: 723-730
[Abstract][Full Text]
Kawai, K., Takaoka, E.-I., Naoi, M., Mori, K., Minami, M., Shimazui, T., Akaza, H.
(2006). A Case of Metastatic Testicular Cancer Complicated by Tumour Lysis Syndrome and Choriocarcinoma Syndrome. Jpn J Clin Oncol
36: 665-667
[Abstract][Full Text]
Kawai, K., Ando, S., Hinotsu, S., Oikawa, T., Sekido, N., Miyanaga, N., Shimazui, T., Akaza, H.
(2006). Completion and Toxicity of Induction Chemotherapy for Metastatic Testicular Cancer: An Updated Evaluation of Japanese Patients. Jpn J Clin Oncol
36: 425-431
[Abstract][Full Text]
Kondagunta, G. V., Motzer, R. J., Bosl, G. J., Sheinfeld, J.
(2006). IN REPLY. JCO
24: 2598-2599
[Full Text]
van den Belt-Dusebout, A. W., Nuver, J., de Wit, R., Gietema, J. A., ten Bokkel Huinink, W. W., Rodrigus, P. T.R., Schimmel, E. C., Aleman, B. M.P., van Leeuwen, F. E.
(2006). Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer. JCO
24: 467-475
[Abstract][Full Text]
Ronnen, E. A., Kondagunta, G. V., Bacik, J., Marion, S., Bajorin, D. F., Sheinfeld, J., Bosl, G. J., Motzer, R. J.
(2005). Incidence of Late-Relapse Germ Cell Tumor and Outcome to Salvage Chemotherapy. JCO
23: 6999-7004
[Abstract][Full Text]
Kondagunta, G. V., Bacik, J., Donadio, A., Bajorin, D., Marion, S., Sheinfeld, J., Bosl, G. J., Motzer, R. J.
(2005). Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors. JCO
23: 6549-6555
[Abstract][Full Text]
Mykletun, A., Dahl, A. A., Haaland, C. F., Bremnes, R., Dahl, O., Klepp, O., Wist, E., Fossa, S. D.
(2005). Side Effects and Cancer-Related Stress Determine Quality of Life in Long-Term Survivors of Testicular Cancer. JCO
23: 3061-3068
[Abstract][Full Text]
Brown, J., Shvartsman, H. S., Deavers, M. T., Burke, T. W., Munsell, M. F., Gershenson, D. M.
(2004). The Activity of Taxanes in the Treatment of Sex Cord-Stromal Ovarian Tumors. JCO
22: 3517-3523
[Abstract][Full Text]
Sakurai, H., Asamura, H., Suzuki, K., Watanabe, S.-i., Tsuchiya, R.
(2004). Management of Primary Malignant Germ Cell Tumor of the Mediastinum. Jpn J Clin Oncol
34: 386-392
[Abstract][Full Text]
Toumi, N., Chaumette-Plankaert, M.-T., Cherqui, D., de Revel, T., Duvillard, P., Theodore, C.
(2004). Germ Cell Tumors: CASE 3. Primary Yolk Sac Tumor of the Liver. JCO
22: 1756-1758
[Full Text]
Kondagunta, G. V., Sheinfeld, J., Mazumdar, M., Mariani, T. V., Bajorin, D., Bacik, J., Bosl, G. J., Motzer, R. J.
(2004). Relapse-Free and Overall Survival in Patients With Pathologic Stage II Nonseminomatous Germ Cell Cancer Treated With Etoposide and Cisplatin Adjuvant Chemotherapy. JCO
22: 464-467
[Abstract][Full Text]
Motzer, R. J., Sheinfeld, J.
(2003). Poor-Risk Testicular Cancer and High-Dose Chemotherapy. JCO
21: 4073-4074
[Full Text]
Schmoll, H.-J., Kollmannsberger, C., Metzner, B., Hartmann, J.T., Schleucher, N., Schoffski, P., Schleicher, J., Rick, O., Beyer, J., Hossfeld, D., Kanz, L., Berdel, W.E., Andreesen, R., Bokemeyer, C.
(2003). Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group. JCO
21: 4083-4091
[Abstract][Full Text]
Miyazaki, J., Kawai, K., Hayashi, H., Onozawa, M., Tsukamoto, S., Miyanaga, N., Hinotsu, S., Shimazui, T., Akaza, H.
(2003). The Limited Efficacy of Methotrexate, Actinomycin D and Cisplatin (MAP) for Patients with Advanced Testicular Cancer. Jpn J Clin Oncol
33: 391-395
[Abstract][Full Text]
Schumer, S. T., Cannistra, S. A.
(2003). Granulosa Cell Tumor of the Ovary. JCO
21: 1180-1189
[Abstract][Full Text]
Kawai, K., Miyazaki, J., Tsukamoto, S., Hinotsu, S., Hattori, K., Shimazui, T., Akaza, H.
(2003). Paclitaxel, Ifosfamide and Cisplatin Regimen is Feasible for Japanese Patients with Advanced Germ Cell Cancer. Jpn J Clin Oncol
33: 127-131
[Abstract][Full Text]
Einhorn, L. H.
(2002). Inaugural Article: Curing metastatic testicular cancer. Proc. Natl. Acad. Sci. USA
99: 4592-4595
[Abstract][Full Text]
Hinton, S., Catalano, P., Einhorn, L. H., Loehrer, P. J. Sr, Kuzel, T., Vaughn, D., Wilding, G.
(2002). Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors (E9897): A Trial of the Eastern Cooperative Oncology Group. JCO
20: 1859-1863
[Abstract][Full Text]
Vaughn, D. J., Gignac, G. A., Meadows, A. T.
(2002). Long-Term Medical Care of Testicular Cancer Survivors. ANN INTERN MED
136: 463-470
[Abstract][Full Text]
Fizazi, K., Chen, I., Logothetis, C. J.
(2002). Germ-cell tumor survivors: the price for cure. Ann Oncol
13: 187-189
[Full Text]
Strumberg, D., Brugge, S., Korn, M. W., Koeppen, S., Ranft, J., Scheiber, G., Reiners, C., Mockel, C., Seeber, S., Scheulen, M. E.
(2002). Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol
13: 229-236
[Abstract][Full Text]
Fizazi, K., Do, K.-A., Wang, X., Finn, L., Logothetis, C. J., Amato, R. J.
(2002). A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial. Ann Oncol
13: 125-134
[Abstract][Full Text]
Dearnaley, D., Huddart, R., Horwich, A
(2001). Regular review: Managing testicular cancer. BMJ
322: 1583-1588
[Full Text]
Gough, M H, Buss, P., Wilson, T., Turton, C., Nottingham, J., Rubin, G., Horton, R., Maran, N. J, Glavin, R. J, Grunewald, R. A, Mack, C. J, Root, T., Stefanou, A., Siderov, J., de Lemos, M., Langford, N J, Martin, U, Kendall, M J, Ferner, R E, Smith, N., Burns-Cox, N., Solomon, L., Holmes, S.
(2001). Medical errors. BMJ
322: 1421-1421
[Full Text]
de Wit, R., Roberts, J. T., Wilkinson, P. M., de Mulder, P. H.M., Mead, G. M., Fossa, S. D., Cook, P., de Prijck, L., Stenning, S., Collette, L.
(2001). Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. JCO
19: 1629-1640
[Abstract][Full Text]
Zanetta, G., Bonazzi, C., Cantu, M. G., Locatelli, A., Bratina, G., Mangioni, C.
(2001). Survival and Reproductive Function After Treatment of Malignant Germ Cell Ovarian Tumors. JCO
19: 1015-1020
[Abstract][Full Text]
Packer, R. J., Cohen, B. H., Coney, K.
(2000). Intracranial Germ Cell Tumors. The Oncologist
5: 312-320
[Abstract][Full Text]
Motzer, R. J., Sheinfeld, J., Mazumdar, M., Bains, M., Mariani, T., Bacik, J., Bajorin, D., Bosl, G. J.
(2000). Paclitaxel, Ifosfamide, and Cisplatin Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Cancer. JCO
18: 2413-2418
[Abstract][Full Text]
Mans, D. R.A., da Rocha, A. B., Schwartsmann, G.
(2000). Anti-Cancer Drug Discovery and Development in Brazil: Targeted Plant Collection as a Rational Strategy to Acquire Candidate Anti-Cancer Compounds. The Oncologist
5: 185-198
[Abstract][Full Text]
Meinardi, M. T., Gietema, J. A., van der Graaf, W. T. A., van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., de Vries, E. G. E., Willemse, P. B. H., Mulder, N. H., van den Berg, M. P., Koops, H. S., Sleijfer, D. Th.
(2000). Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer. JCO
18: 1725-1732
[Abstract][Full Text]
Hainsworth, J. D., Lennington, W. J., Greco, F. A.
(2000). Overexpression of Her-2 in Patients With Poorly Differentiated Carcinoma or Poorly Differentiated Adenocarcinoma of Unknown Primary Site. JCO
18: 632-632
[Abstract][Full Text]
Amato, R. J., Millikan, R., Daliani, D., Wood, L., Logothetis, C., Pollack, A.
(2000). Cyclophosphamide and Carboplatin and Selective Consolidation in Advanced Seminoma. Clin. Cancer Res.
6: 72-77
[Abstract][Full Text]
Kesler, K. A., Rieger, K. M., Ganjoo, K. N., Sharma, M., Fineberg, N. S., Einhorn, L. H., Brown, J. W.
(1999). PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM CELL TUMORS: THE INFLUENCE OF POSTCHEMOTHERAPY PATHOLOGY ON LONG-TERM SURVIVAL AFTER SURGERY. J. Thorac. Cardiovasc. Surg.
118: 692-701
[Abstract][Full Text]
Brewer, M., Gershenson, D. M., Herzog, C. E., Mitchell, M. F., Silva, E. G., Wharton, J. T.
(1999). Outcome and Reproductive Function After Chemotherapy for Ovarian Dysgerminoma. JCO
17: 2670-2670
[Abstract][Full Text]
Buckner, J. C., Peethambaram, P. P., Smithson, W. A., Groover, R. V., Schomberg, P. J., Kimmel, D. W., Raffel, C., O'Fallon, J. R., Neglia, J., Shaw, E. G.
(1999). Phase II Trial of Primary Chemotherapy Followed by Reduced-Dose Radiation for CNS Germ Cell Tumors. JCO
17: 933-933
[Abstract][Full Text]
Einhorn, L. H., Stender, M. J., Williams, S. D.
(1999). Phase II Trial of Gemcitabine in Refractory Germ Cell Tumors. JCO
17: 509-509
[Abstract][Full Text]
Smith, M. A., Rubinstein, L., Anderson, J. R., Arthur, D., Catalano, P. J., Freidlin, B., Heyn, R., Khayat, A., Krailo, M., Land, V. J., Miser, J., Shuster, J., Vena, D.
(1999). Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins. JCO
17: 569-569
[Abstract][Full Text]
Mayer, R. J., Schnipper, L. E., Broder, S., Hughes-Davies, T.H., Rand, T. S., Cole, P., Rodu, B., Corey, S., Suit, H., Isselbacher, K., Chabner, B., Feldman, A., Atkins, R. N., Arlen, P. A., Noxon, C. L., Wilcken, N., Bailar, J. C., Gornik, H. L.
(1997). Winning the War on Cancer. NEJM
337: 935-938
[Full Text]
Bosl, G. J., Motzer, R. J.
(1997). Testicular Germ-Cell Cancer. NEJM
337: 242-254
[Full Text]
Droz, J.-P., Culine, S., Biron, P., Kramar, A.
(1997). High-Dose Chemotherapy in Adult Solid Tumors and Lymphoproliferative Disorders: The Need for Randomized Trials. The Oncologist
2: 83-93
[Abstract][Full Text]
Hainsworth, J. D., Greco, F. A.
(1993). Treatment of Patients with Cancer of an Unknown Primary Site. NEJM
329: 257-263
[Full Text]
Munro, A. J., Warde, P. R.
(1991). The Use of a Markov Process to Simulate and Assess Follow-up Policies for Patients with Malignant Disease: Surveillance for Stage I Nonseminomatous Tumors of the Testis. Med Decis Making
11: 131-139
[Abstract]
Williams, S. D., Blessing, J. A., Moore, D. H., Homesley, H. D., Adcock, L.
(1989). Cisplatin, Vinblastine, and Bleomycin in Advanced and Recurrent Ovarian Germ-Cell Tumors: A Trial of the Gynecologic Oncology Group. ANN INTERN MED
111: 22-27
[Abstract]
Benditt, J. O., Farber, H. W., Wright, J., Karnad, A. B.
(1988). Pulmonary Hemorrhage with Diffuse Alveolar Infiltrates in Men with High-Volume Choriocarcinoma. ANN INTERN MED
109: 674-675
[Abstract]
Trump, D. L., Bartel, E., Pozniak, M.
(1988). Nodular Pneumonitis after Chemotherapy for Germ Cell Tumors. ANN INTERN MED
109: 431-432
[Abstract]
Einhorn, L. H.
(2002). Inaugural Article: Curing metastatic testicular cancer. Proc. Natl. Acad. Sci. USA
99: 4592-4595
[Abstract][Full Text]
Previous
